Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Avoid Slam: Exploring the Pickup Truck Transformation - 2Instructions to Adjust Work, Life, and Seeking after a Web based Advertising Degree
- 3Find Unexpected, yet invaluable treasure Excursion Rentals
- 4From Exemplary to Current: Famous Rings Available
- 5Live long and loiter: Why NASA's ESCAPADE probes will wait a year in space before heading to Mars
- Doritos and Cheetos dial back the bright orange in new versions without artificial ingredients
- Flu illness count nears 5 million, with New York City among the hardest hit
- Poll: Only 25% of Americans think Trump has 'followed through' on his promise to release the Epstein files
- Jury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders
- Abbott issues US device correction for some glucose monitors over faulty readings risk
- Interstellar comet 3I/ATLAS' journey through our solar system, in photos
- Figure out How to Streamline Eco-friendliness in Your Volvo XC40
- Pleasant Cycle Courses All over the Planet
- Inside Plan with Houseplants: An Aide
